Catastrophic Costs Potentially Averted by TB Control in India and South Africa
2017
This study estimated the reduction in tuberculosis-related catastrophic costs with an aggressive expansion of tuberculosis services in India and South Africa from 2016 to 2035, in line with the End TB Strategy. The authors investigated three intervention scenarios: improved treatment of drug-sensitive tuberculosis; improved treatment of multidrug-resistant tuberculosis; and expansion of access to tuberculosis care through intensified case finding (South Africa only).
In India and South Africa, improvements in treatment for drug-sensitive and multidrug-resistant tuberculosis could reduce the number of households incurring tuberculosis-related catastrophic costs by 6–19%. The benefits would be greatest for the poorest households. In South Africa, expanded access to care could decrease household tuberculosis-related catastrophic costs by 5–20%, but gains would be seen largely after 5–10 years.
Catastrophic Costs Potentially Averted by TB Control in India and South Africa
Source:
Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA et al. Catastrophic Costs Potentially Averted by Tuberculosis Control in India and South Africa: A Modelling Study. The Lancet Global Health 2017; 5 (11): e1123-e1132. https://doi.org/10.1016/S2214-109X(17)30341-8